Isradipine
Dynacirc (isradipine) is a small molecule pharmaceutical. Isradipine was first approved as Dynacirc on 1990-12-20. It is used to treat hypertension and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D, voltage-dependent L-type calcium channel subunit alpha-1F, voltage-dependent L-type calcium channel subunit alpha-1S, and voltage-dependent L-type calcium channel subunit alpha-1C.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
isradipine | ANDA | 2023-06-09 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypertension | EFO_0000537 | D006973 | I10 |
variant angina pectoris | — | D000788 | I20.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
44 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Invasive fungal infections | D000072742 | — | — | 2 | — | 1 | 3 | ||
Aspergillosis | D001228 | EFO_0007157 | B44 | — | — | 3 | — | — | 3 |
Myeloid leukemia acute | D015470 | C92.0 | — | 2 | 1 | — | — | 2 | |
Candidemia | D058387 | EFO_1001282 | — | — | 1 | — | — | 1 | |
Invasive candidiasis | D058365 | EFO_1001283 | B37 | — | — | 1 | — | — | 1 |
Mycoses | D009181 | B35-B49 | — | — | 1 | — | — | 1 | |
Sars-cov-2 | D000086402 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 25 | — | — | — | — | 25 | ||
Pharmacokinetics | D010599 | 3 | — | — | — | — | 3 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ISRADIPINE |
INN | isradipine |
Description | Isradipine is an isopropyl ester, a methyl ester, a dihydropyridine and a benzoxadiazole. |
Classification | Small molecule |
Drug class | phenylpyridine vasodilators; tricyclic compounds |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12 |
Identifiers
PDB | — |
CAS-ID | 75695-93-1 |
RxCUI | 33910 |
ChEMBL ID | CHEMBL1648 |
ChEBI ID | — |
PubChem CID | 3784 |
DrugBank | DB00270 |
UNII ID | YO1UK1S598 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
CACNA1D
CACNA1D
CACNA1F
CACNA1F
CACNA1S
CACNA1S
CACNA1C
CACNA1C
Organism
Homo sapiens
Gene name
CACNA1D
Gene synonyms
CACH3, CACN4, CACNL1A2, CCHL1A2
NCBI Gene ID
Protein name
voltage-dependent L-type calcium channel subunit alpha-1D
Protein synonyms
calcium channel, L type, alpha-1 polypeptide, Calcium channel, L type, alpha-1 polypeptide, isoform 2, calcium channel, neuroendocrine/brain-type, alpha 1 subunit, calcium channel, voltage-dependent, L type, alpha 1D subunit, voltage-gated calcium channel alpha 1 subunit, voltage-gated calcium channel alpha subunit Cav1.3, Voltage-gated calcium channel subunit alpha Cav1.3
Uniprot ID
Mouse ortholog
Cacna1d (12289)
voltage-dependent L-type calcium channel subunit alpha-1D (Q99246)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,863 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,366 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more